Cognitive Dysfunction and Depression in Adult Kidney Transplant Recipients: Baseline Findings from the FAVORIT Ancillary Cognitive Trial (FACT)

Journal of Renal Nutrition

Volumn 22, Issue 2, 2012, Pages

  Troen, Aron M ^a,b   Scott, Tammy M ^a,c   D'Anci, Kristen E ^a   Moorthy, Denish ^a   Dobson, Beverly ^a   Rogers, Gail ^a   Weiner, Daniel E ^c   Levey, Andrew S ^c   Dallal, Gerard E ^a   Jacques, Paul F ^a   Selhub, Jacob ^a   Rosenberg, Irwin H ^a  

^a TUFTS UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857369149     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.07.009     Document Type: Article

References (54)

1. Clarke R., Smith A.D., Jobst K.A., et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998, 55:1449-1455.
2. Kado D.M., Karlamangla A.S., Huang M.H., et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: macarthur studies of successful aging. Am J Med 2005, 118:161-167.
3. Riggs K.M., Spiro A., Tucker K., et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 1996, 63:306-314.
4. Troen A., Rosenberg I. Homocysteine and cognitive function. Semin Vasc Med 2005, 5:209-214.
5. Bertsch T., Mielke O., Holy S., et al. Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 2001, 39:721-724.
6. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004, 226:25-29.
7. Selhub J., Bagley L.C., Miller J., et al. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000, 71:614S-620S.
8. Bostom A.G., Gohh R.Y., Beaulieu A.J., et al. Treatment of hyperhomocysteinemia in renal transplant recipients: a randomized, placebo-controlled trial. Ann Intern Med 1997, 127:1089-1092.
9. Bostom A.G., Carpenter M.A., Kusek J.W., et al. Rationale and design of the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial. Am Heart J 2006, 152:448. e1-448.e7.
10. Kasiske B.L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988, 84:985-992.
11. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis 1998, 32:853-906.
12. Bostom A.G., Culleton B.F. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999, 10:891-900.
13. Brady C.B., Gaziano J.M., Cxypoliski R.A., et al. Homocysteine lowering and cognition in CKD: the veterans affairs homocysteine study. Am J Kidney Dis 2009, 54:440-449.
14. Mann J.F., Sheridan P., McQueen M.J., et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease-results of the renal Hope-2 study. Nephrol Dial Transplant 2008, 23:645-653.
15. Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N Engl J Med 2006, 354:1629-1632.
16. Durga J., van Boxtel M.P., Schouten E.G., et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369:208-216.
17. Scheltens P., Kamphuis P.J., Verhey F.R., et al. Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement 2010, 6:1. e1-10.e1.
18. Smith A.D., Smith S.M., de Jager C.A., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010, 5:e12244.
19. Spence J.D. Perspective on the efficacy analysis of the vitamin intervention for stroke prevention trial. Clin Chem Lab Med 2007, 45:1582-1585.
20. Spence J.D., Bang H., Chambless L.E., et al. Vitamin intervention for stroke prevention trial: an efficacy analysis. Stroke 2005, 36:2404-2409.
21. Bostom A.G., Carpenter M.A., Hunsicker L., et al. Baseline characteristics of participants in the folic acid for vascular outcome reduction in transplantation (favorit) trial. Am J Kidney Dis 2009, 53:121-128.
22. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
23. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987, 422:43-52.
24. Levey A.S., Coresh J., Greene T., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
25. Shin Y.S., Rasshofer R., Friedrich B., et al. Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin Chim Acta 1983, 127:77-85.
26. Blair J.R., Spreen O. Predicting premorbid IQ: A revision of the National Adult Reading Test. Clinical Neuropsychologist 1989, 3. 129-126.
27. Heaton R., Grant I., Matthews C. Comprehensive Norms for an Expanded Halstead-Reitan Battery 1991, Psychological Assessment Resources, Inc., Odessa Florida.
28. Wechsler Adult Intelligence Scale - Third Edition (WAIS-III), Wechsler Memory Scale - Third Scale (WMS-III): Technical Manual 1997, The Psychological Corporation /Harcourt Brace & Co., San Antonio. D. Tulsky, J. Zhu, M. Lebetter (Eds.).
29. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
30. Griva K., Hansraj S., Thompson D., et al. Neuropsychological performance after kidney transplantation: a comparison between transplant types and in relation to dialysis and normative data. Nephrol Dial Transplant 2004, 19:1866-1874.
31. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd ed.
32. Weiner D.E. The cognition-kidney disease connection: lessons from population-based studies in the United States. Am J Kidney Dis 2008, 52:201-204.
33. Seliger S.L., Siscovick D.S., Stehman-Breen C.O., et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol 2004, 15:1904-1911.
34. Zoungas S., Kerr P.G., Chadban S., et al. Arterial function after successful renal transplantation. Kidney Int 2004, 65:1882-1889.
35. Rao R. The role of carotid stenosis in vascular cognitive impairment. J Neurol Sci 2002, 203-204:103-107.
36. Kurella Tamura M., Wadley V., Yaffe K., et al. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis 2008, 52:227-234.
37. Jokinen H., Kalska H., Mantyla R., et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2006, 77:28-33.
38. Jokinen H., Kalska H., Ylikoski R., et al. Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol 2004, 11:825-832.
39. Van der Flier W.M., Middelkoop H.A., Weverling-Rijnsburger A.W., et al. Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age. Dement Geriatr Cogn Disord 2005, 20:82-88.
40. Thomas A.J., Perry R., Kalaria R.N., et al. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 2003, 18:7-13.
41. Kannel W., Gordon T. The Framingham Study: an Epidemiological Investigation of Cardiovascular Disease 1977, Department of Health, Education, and Welfare, Washington, DC, 94-103.
42. Gelb S., Shapiro R.J., Hill A., et al. Cognitive outcome following kidney transplantation. Nephrol Dial Transplant 2008, 23:1032-1038.
43. Palmer K., Fratiglioni L., Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand Suppl 2003, 179:14-20.
44. Palmer K., Wang H.X., Backman L., et al. Differential evolution of cognitive impairment in nondemented older persons: results from the kungsholmen project. Am J Psychiatry 2002, 159:436-442.
45. Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
46. Antoniades C., Shirodaria C., Leeson P., et al. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009, 119:2507-2515.
47. Weiner D.E., Bartolomei K., Scott T., et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009, 53:438-447.
48. Finkelstein F.O., Wuerth D., Troidle L.K., et al. Depression and end-stage renal disease: a therapeutic challenge. Kidney Int 2008, 74:843-845.
49. Akman B., Ozdemir F.N., Sezer S., et al. Depression levels before and after renal transplantation. Transplant Proc 2004, 36:111-113.
50. Kimmel P.L., Peterson R.A. Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial 2005, 18:91-97.
51. Overbeck I., Bartels M., Decker O., et al. Changes in quality of life after renal transplantation. Transplant Proc 2005, 37:1618-1621.
52. Tossani E., Cassano P., Fava M. Depression and renal disease. Semin Dial 2005, 18:73-81.
53. Sachdev P.S., Parslow R.A., Lux O., et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med 2005, 35:529-538.
54. Tolmunen T., Hintikka J., Voutilainen S., et al. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am J Clin Nutr 2004, 80:1574-1578.